Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gluteal device for penile injection.

A M Helmy1

  • 1Dr. Helmy Clinic, Jeddah, Saudi Arabia.

British Journal of Urology
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

An implantable device simplifies self-injection for treating male impotence with vasodilator drugs. This innovation allows more patients to effectively manage erectile dysfunction through convenient, localized drug delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cisatracurium in different doses versus atracurium during general anesthesia for abdominal surgery.

Saudi journal of anaesthesiaยท2010
See all related articles

Area of Science:

  • Urology
  • Andrology
  • Medical Devices

Background:

  • Locally acting vasodilator drugs are a treatment for male impotence (erectile dysfunction).
  • Self-injection of these drugs can be challenging for some patients.
  • Existing methods may limit accessibility for a broader patient demographic.

Purpose of the Study:

  • To assess the efficacy and usability of an implantable device for self-injection of vasodilator drugs.
  • To determine if the device can overcome difficulties associated with traditional self-injection methods.
  • To expand treatment options for male impotence.

Main Methods:

  • An implantable device was utilized to facilitate self-administration of vasodilator drugs.
  • Thirty-seven patients were treated using this novel approach.

Related Experiment Videos

  • Treatment outcomes were monitored between January 1987 and September 1988.

    • Main Results:

    • The implantable device enabled successful self-injection for patients.
    • Thirty-seven patients received successful treatment.
    • The device facilitated wider patient access to this form of therapy.

    Conclusions:

    • The implantable device is an effective solution for overcoming self-injection difficulties in male impotence treatment.
    • This technology improves patient compliance and accessibility to vasodilator therapy.
    • The device represents a significant advancement in managing erectile dysfunction.